The Analytical Data Management Report
From new instruments and software to the rise of the digital lab, the landscape of analytical chemistry data is constantly evolving. To stay on top of trends, we launch a comprehensive survey every few years focused on analytical chemistry data and its management. Here's what we learned.
Automated Structure Verification for High-Throughput Quality Control in Pharmaceutical R&D—Part 2
Amgen’s Structural Chemistry Group uses automated structure verification (ASV) to streamline data analysis, enhance decision-making, and reduce errors. Read how they’ve taken advantage of this in their high-throughput NMR workflow to perform quality control on all the samples in their sample bank and enable rapid analysis of up to 5,000 compounds annually.
Accelerating Structure Verification Across Novartis
Novartis implemented automated structure verification (ASV) across 15 open access NMR instruments, reducing data analysis time for chemists by up to 90%. Learn how they are continuing to improve accuracy and how the system is helping one pharmaceutical development team focus on complex elucidations that require expert insight.
Automated Verification of Small Molecule Structures at Sanofi
Sanofi’s implemented automated structure verification (ASV) to streamline 1H NMR-based molecule validation, reducing repetitive tasks and improving efficiency. Learn more about their testing that revealed how LIMS integration, prediction database updates, and LC/MS integration, ensures reliable verification, enhancing chemists' workflow.
Automated Structure Verification for High-Throughput Quality Control in Pharmaceutical R&D—Part 1
Syngenta’s NMR team used automated structure verification (ASV) to perform high-throughput quality control of the more than 2000 materials in their chemistry store. Learn how they determined the optimal NMR dataset to minimize instrument time and then used ASV to reduce data analysis time by nearly 50%.
Building a Foundation for Autonomous Structure Verification with ASV
Learn how AstraZeneca are building on their two decades of digitalizing NMR data analysis to automate structure verification. Their current ASV system enhances efficiency for synthetic chemists without compromising accuracy. Meanwhile, they continue to explore ways to improve, including integrating diverse analytical data, with their sights ultimately set on a fully autonomous system.
Streamline Stability Decisions in Pharmaceutical Development
This webinar highlights how Luminata® simplifies pharmaceutical stability decisions by integrating forced degradation and APS data. Learn to visualize analytical data, map degradant pathways, and model stability trends for faster, more informed decision-making.
Register Now: Thursday, May 8th, 10 AM EDT